北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科  > 期刊论文
学科主题: 感染疾病科
题名:
核苷(酸)类抗病毒药物治疗慢性乙型肝炎患者HBV DNA与HBsAg定量的5年动态分析
其他题名: Antiviral nucleotide-induced dynamic change of HBV DNA and HBsAg and significance of quarterly and annual quantitative measurements over 5-year follow-up of chronic hepatitis B patients
作者: 席宏丽; 李敏然; 鲍毅; 于敏; 秦小琪; 徐小元
关键词: 肝炎,乙型,慢性 ; 肝炎表面抗原,乙型 ; DNA,肝炎病毒,乙型 ; 核苷(酸)类抗病毒药 ; Hepatitis B,chronic ; Hepatitis B surface antigen ; HBV DNA ; Nucleotide (acid) antivirus drug
刊名: 中华肝脏病杂志
发表日期: 2013
DOI: 10.3760/cma.j.issn.1007-3418.2013.11.006
卷: 21, 期:11, 页:821-824
收录类别: 中国科技核心期刊 ; 中文核心期刊 ; CSCD
文章类型: Journal Article
摘要: 目的 分析慢性乙型肝炎患者应用核苷(酸)类抗病毒药物治疗,动态观察HBVDNA与HBsAg定量.方法 110例慢性乙型肝炎患者初始应用单种核苷类药物抗病毒治疗,每三个月随访一次,检测HBV五项标志物、HBV DNA,每隔1年检测HBsAg定量,用SPSS13.0统计软件分析比较HBV DNA与HBsAg定量的5年变化.根据资料不同分别采用方差分析和x2检验进行统计学分析.结果 110例患者中,在随访第5年仍有90例应用单药治疗.HBeAg阳性的HBVDNA与HBsAg定量均高于HBeAg阴性的患者.随着抗病毒治疗时间的延长,慢性乙型肝炎患者的HBsAg和HBV DNA均有下降趋势(F值分别为17.1和151.53,P值均<0.05),HBV DNA在随访第1年下降最明显.结论 HBeAg阴性和HBeAg阳性慢性乙型肝炎患者HBV DNA与HBsAg定量均随着核苷(酸)类抗病毒药物治疗时间的延长而下降;HBV DNA在治疗一年内下降幅度最大,HBsAg定量在随访后3年与基线水平比较,差异有统计学意义. Objective To analyze the dynamic changes in hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) levels in chronic hepatitis B (CHB) patients following treatment by antiviral nucleotide drugs over a 5-year follow-up period and to assess the clinical significance of quarterly and annual quantitative measurements.Methods One-hundred-and-ten patients with CHB were enrolled in the study and administered on-going standard mono-therapy with various antiviral nucleotide drugs.Over a 5-year period,the HBV DNA level was measured by quantitative PCR every three months and the HBsAg levels were measured by chemiluminescence once a year.The dynamic changes in HBV DNA and HBsAg levels were assessed by Chi-squared test and ANOVA.Results Only 90 of the CHB patients completed the 5-year follow-up and were included in the analysis.The patients who showed HBeAgpositivity at baseline (study start) had higher levels ofHBV DNA and HBsAg than the patients showing HBeAgnegativity.In general,the antiviral nucleotide drug therapy induced downward trends in HBsAg and HBV DNA level over time (F =17.1,151.53,all P < 0.05).However,the most robust reduction in HBV DNA occurred during the fust year.The HBsAg level followed an opposite trend,with the most robust reductions occurring in the 3rd,4th and 5th years of treatment.Conclusion Long-term antiviral nucleotide mono-therapies induced decreases in HBV DNA and HBsAg levels in CHB patients,with the former being most reduced in the short-term and the latter in the long-term.
语种: 中文
原文出处: 查看原文
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/41855
Appears in Collections:北京大学第一临床医学院_感染疾病科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 100034,北京大学第一医院感染性疾病科
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[席宏丽]'s Articles
[李敏然]'s Articles
[鲍毅]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[席宏丽]‘s Articles
[李敏然]‘s Articles
[鲍毅]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace